References
- Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 1988; 319: 1681–92
- Fisher B, Redmond C, Dimitrov N V, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen receptor-negative tumors. N Engl J Med 1989; 320: 473–8
- The Ludwig Breast Cancer Study Group. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 1989; 320: 491–6
- Carbone PP. Breast cancer adjuvant therapy. Cancer 1990; 66: 1378–86
- Toikkanen S, Joensuu H, Klemi PJ. Prognostic significance of DNA content in T1–2N0 breast cancer. Am J Clin Pathol 1990; 93: 471–9
- Histological typing of breast tumors. International histological classification of tumors No. 2.Second ed. WHO, Geneva 1981
- Hedley D W, Friedlander M L, Taylor I W, Rugg C A, Mus-Grove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem Cytochem 1983; 31: 1333–5
- Toikkanen S, Joensuu H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer—A study with long-term follow-up. Br J Cancer 1989; 60: 693–700
- Camplejohn R S, Macartney J C, Morris RW. Measurement of S-phase fractions in lymphoid tissue comparing fresh versus paraffin-embedded tissue and 4′,6′-diamino-2 phenylindole dihydrochloride versus propidium iodide staining. Cytometry 1989; 10: 410–6
- Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972; 34: 187–220
- Toikkanen S, Joensuu H. Prognostic factors and long-term survival in breast cancer in a defined urban population. APMIS 1990; 98: 1005–14
- Rosen P P, Groshen S. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Surg Clin N Am 1990; 70: 937–62
- Rosen P P, Groshen S, Saigo P E, Kinne D W, Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7: 355–66
- Rosner D, Lane WW. Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapy. Cancer 1990; 66: 199–205
- Carter C L, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181–7
- Bedwani R, Vana J, Rosner D, Schmitz R L, Murphy GP. Management and survival of female patients with 'minimal breast cancer'. Cancer 1981; 47: 2769–78
- Fornander T, Rutqvist L E, Cedermark B, et al. Ajuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1989; 1: 117–20
- Curtis R E, Boice J D, Moloney W C, Ries L G, Flannery JT. Leukemia following chemotherapy for breast cancer. Cancer Res 1990; 50: 2741–6